Age-related macular degeneration and recent developments: new hope for old eyes?. Issue 979 (8th May 2007)

• Record Type: Journal Article
• Authors: Morris, Brid; Imrie, Fraser; Armbrecht, Ana-Maria; Dhillon, Baljean
• Is Part Of: Postgraduate medical journal. Volume 83:Issue 979(2007)
• Page Start: 301
• Page End: 307
• Publication Date: 2007-05-08
• Subjects: AMD, age-related macular degeneration -- CNV, choroidal neovascular membrane -- IOL, intraocular lens -- PDT, photodynamic therapy -- RNIB, Royal National Institute for the Blind -- VEGF, vascular endothelial derived growth factor; age-related macular degeneration -- blindness -- choroidal neovascular membrane -- elderly -- photodynamic therapy -- quality of life; Medicine -- Periodicals; 610
• DOI: 10.1136/pgmj.2006.052944
• Languages: English
• ISSNs: 0032-5473

Abstract

Abstract : Age-related macular degeneration (AMD) is the commonest cause of blindness in the population over 60 years of age and accounts for over 50% of those registered blind in the UK. The incidence is increasing and as older generations live longer a growing number of patients will be affected in the future. Affected patients lose central vision, important in all aspects of everyday life. This review outlines risk factors for AMD, clinical features, treatment and management strategies for patients, families and physicians caring for those with AMD. Recent trials are included along with practical clinical advice. While there is no curative treatment at present, intervention can reduce the risk of developing AMD and limit disease progression if it occurs. These modalities are discussed here. As new discoveries in the field of genetics and novel therapies emerge, a brighter future seems certain for the ageing population.